P. Merle

405 total citations
5 papers, 333 citations indexed

About

P. Merle is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, P. Merle has authored 5 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in P. Merle's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Hepatitis B Virus Studies (1 paper). P. Merle is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Hepatitis B Virus Studies (1 paper). P. Merle collaborates with scholars based in United States, France and Japan. P. Merle's co-authors include Margaret Mooney, Lawrence Schwartz, Alan P. Venook, Bert H. O’Neil, Steven A. Curley, Deborah Jaffe, Robert K. Kerlan, Joel E. Tepper, Ronnie T.P. Poon and Melanie B. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

P. Merle

5 papers receiving 328 citations

Peers

P. Merle
P. Merle
Citations per year, relative to P. Merle P. Merle (= 1×) peers Cheng‐Qian Zhong

Countries citing papers authored by P. Merle

Since Specialization
Citations

This map shows the geographic impact of P. Merle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Merle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Merle more than expected).

Fields of papers citing papers by P. Merle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Merle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Merle. The network helps show where P. Merle may publish in the future.

Co-authorship network of co-authors of P. Merle

This figure shows the co-authorship network connecting the top 25 collaborators of P. Merle. A scholar is included among the top collaborators of P. Merle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Merle. P. Merle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Merle, P., Masashi Kudo, Catherine Frenette, et al.. (2020). 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study. Annals of Oncology. 31. S699–S700. 3 indexed citations
2.
Thomas, Melanie B., Deborah Jaffe, Jacques Belghiti, et al.. (2010). Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology. 28(25). 3994–4005. 324 indexed citations
3.
Trépo, C., et al.. (2006). O.128 Long-term maintenance ribavirin monotherapy in chronic hepatitis C patients not responding or intolerant to interferon alpha. Journal of Clinical Virology. 36. S39–S39. 1 indexed citations
4.
Chevallier, Marie, et al.. (2004). 518 Long-term ribavirin monotherapy in patients with chronic hepatitis C not responding or intolerant to interferon alpha. Journal of Hepatology. 40. 152–153. 3 indexed citations
5.
Guillard, Olivier, et al.. (1990). Severe selective magnesium malabsorption: tests of tolerance of oral magnesium supplements.. PubMed. 3(4). 291–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026